These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21535909)

  • 1. Fibrin gel improves the survival of transplanted myoblasts.
    Gerard C; Forest MA; Beauregard G; Skuk D; Tremblay JP
    Cell Transplant; 2012; 21(1):127-37. PubMed ID: 21535909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan enhances the success of myoblast transplantation.
    Fakhfakh R; Lamarre Y; Skuk D; Tremblay JP
    Cell Transplant; 2012; 21(1):139-52. PubMed ID: 21535912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise improves the success of myoblast transplantation in mdx mice.
    Bouchentouf M; Benabdallah BF; Mills P; Tremblay JP
    Neuromuscul Disord; 2006 Aug; 16(8):518-29. PubMed ID: 16919954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene.
    Moisset PA; Skuk D; Asselin I; Goulet M; Roy B; Karpati G; Tremblay JP
    Biochem Biophys Res Commun; 1998 Jun; 247(1):94-9. PubMed ID: 9636661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice.
    Benabdallah BF; Bouchentouf M; Rousseau J; Tremblay JP
    Cell Transplant; 2009; 18(7):709-18. PubMed ID: 19520047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal myoblast implantation in MDX mice prevents muscle damage by exercise.
    Brussee V; Merly F; Tardif F; Tremblay JP
    Biochem Biophys Res Commun; 1998 Sep; 250(2):321-7. PubMed ID: 9753628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Co-transplantation of myoblasts and schwann cells in the therapy of Duchenne muscular dystrophy].
    Luo L; Zhou HY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):101-5. PubMed ID: 21355312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage.
    Rousseau J; Dumont N; Lebel C; Quenneville SP; Côté CH; Frenette J; Tremblay JP
    Cell Transplant; 2010; 19(5):589-96. PubMed ID: 20650035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irradiation of dystrophic host tissue prior to myoblast transfer therapy enhances initial (but not long-term) survival of donor myoblasts.
    Hodgetts SI; Grounds MD
    J Cell Sci; 2003 Oct; 116(Pt 20):4131-46. PubMed ID: 12972504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
    Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y
    Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model.
    Torrente Y; Camirand G; Pisati F; Belicchi M; Rossi B; Colombo F; El Fahime M; Caron NJ; Issekutz AC; Constantin G; Tremblay JP; Bresolin N
    J Cell Biol; 2003 Aug; 162(3):511-20. PubMed ID: 12885758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for natural killer cells in the rapid death of cultured donor myoblasts after transplantation.
    Hodgetts SI; Spencer MJ; Grounds MD
    Transplantation; 2003 Mar; 75(6):863-71. PubMed ID: 12660516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts.
    Moisset PA; Gagnon Y; Karpati G; Tremblay JP
    Gene Ther; 1998 Oct; 5(10):1340-6. PubMed ID: 9930339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AG490 improves the survival of human myoblasts in vitro and in vivo.
    Gérard C; Dufour C; Goudenege S; Skuk D; Tremblay JP
    Cell Transplant; 2012; 21(12):2665-76. PubMed ID: 22963730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
    Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
    Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.
    Fakhfakh R; Michaud A; Tremblay JP
    Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The survival of myoblasts after intramuscular transplantation is improved when fewer cells are injected.
    Pellegrini KL; Beilharz MW
    Transplantation; 2011 Mar; 91(5):522-6. PubMed ID: 21192317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
    Kinoshita I; Huard J; Tremblay JP
    Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
    Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
    J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.